CLINICAL_TRIALS
trial_result
· 2021-08-17
Clinical Trial Update: Effect of CPL-2009-0031 in the Treatment of Patients With Uncontrolled Type 2 Diabetes Mellitus [Phase 3]
Summary
Phase 3 trial update for CPL-2009-0031 in uncontrolled type 2 diabetes mellitus has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Cadila Pharnmaceuticals | Conditions: Uncontrolled Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED